Full history for every metric is available with a Kvantra account
Key financial summary
Financials in CHF| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | TTM | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | CHF m | 2,917 | 2,602 | 3,364 | 3,738 | 3,627 | 3,613 | 3,606 | 3,606 |
| Operating profit | CHF m | 676 | 676 | ||||||
| Net profit | CHF m | 483 | 581 | 649 | 648 | 601 | 541 | 431 | 431 |
| EPS reported | CHF | 7.22 | 7.22 | ||||||
| Operating cashflow per share | CHF | 11.30 | 11.33 | ||||||
| Capex per share | CHF | 1.34 | 1.35 | ||||||
| FCF per share | CHF | 9.96 | 9.98 | ||||||
| Free cash flow | CHF m | 603 | 603 | ||||||
| Net debt | CHF m | 749 | 749 | ||||||
| Book value equity | CHF m | 2,614 | 2,614 | ||||||
| Book value per share | CHF | 43.18 | 43.29 | ||||||
| Number of shares | m | 60.53 | 60.38 | ||||||
| DPS (TTM paid) | CHF | 4.33 | 4.70 |
Financial summary
Financials in CHF| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | TTM | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E TTM | x | 24.79 | - | ||||||
| P/B LTM | x | 4.15 | 5.65 | ||||||
| P/S LTM | x | 3.00 | 4.09 | ||||||
| P/FCF LTM | x | 17.98 | 24.48 | ||||||
| EV/EBITDA LTM | x | 14.05 | 18.43 | ||||||
| EV/Sales LTM | x | 3.28 | 4.30 | ||||||
| Earnings Yield LTM | % | 4.03% | 2.87% | ||||||
| FCF Yield | % | 5.56% | 4.08% | ||||||
| Quality | |||||||||
| ROE | % | 16.47% | 17.08% | ||||||
| ROIC | % | 12.43% | 12.43% | ||||||
| Operating margin | % | 18.74% | 18.74% | ||||||
| Gross margin | % | 73.72% | 73.72% | ||||||
| FCF/Sales | % | 16.71% | 16.71% | ||||||
| Growth and momentum | |||||||||
| EPS Growth YoY | % | -20.13% | -20.13% | ||||||
| Sales Growth YoY | % | -0.19% | -0.19% | ||||||
| Net Income Growth YoY | % | -20.33% | -20.33% | ||||||
| FCF Growth | % | -8.14% | -8.14% | ||||||
| Operating Profit Growth | % | -6.11% | -6.11% | ||||||
| Dividend and capital structure | |||||||||
| Dividend Yield | % | 2.42% | 1.78% | ||||||
| Dividend Growth | % | - | +6.82% | ||||||
| Payout Ratio | % | 60.02% | 60.91% | ||||||
| FCF/Debt | x | 0.35 | 0.35 | ||||||
| Net Debt/EBITDA | x | 1.18 | 1.18 | ||||||
| EBIT/Net interest | x | 23.55 | 7.71 | ||||||
| Net debt/market cap | % | 6.91% | 5.07% | ||||||
| Net debt/Equity | x | 0.29 | 0.29 | ||||||
| Gross debt/equity | x | 0.65 | 0.65 | ||||||
ETFs that hold Sonova Holding
| Fund | Ticker | Position# | Weight |
|---|---|---|---|
| iShares SMIM ETF (CH) | CSSMIM.SW | 8 | 4.65% |
| iShares STOXX Europe Mid 200 UCITS ETF (DE) | EXSD.DE | 10 | 0.80% |
| First Trust International Developed Capital Strength ETF | FICS | 3 | 2.54% |
| Harbor ETF Trust - Harbor Osmosis International Resource Efficient ETF | EFFI | 8 | 3.34% |
Funds with Sonova Holding among their ten largest holdings, largest fund first.
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
Company overview
Headquartered in Stäfa, Switzerland, Sonova Holding AG is a leading provider of innovative hearing care solutions for both adults and children. The company's operations are divided into two primary segments: Hearing Instruments and Cochlear Implants. Sonova's extensive offerings include advanced wireless communication devices, rechargeable hearing aids, wireless headsets, speech-enhanced hearables, premium audiophile headphones, microphones, and wireless transmission systems, alongside comprehensive audiological care services. Its renowned hearing aid brands comprise Phonak, Unitron, and Hansaton, while Advanced Bionics is its flagship for cochlear implants. For consumer audio, Sonova offers products under the Sennheiser brand. The company delivers its audiological care through a vast network of around 3,600 clinics and stores operating under various regional names such as AudioNova, Audium, and Boots Hearingcare, among others. Additionally, its products are distributed via independent partners. Sonova boasts a significant international presence, serving markets across the United States, Europe, the Middle East, Africa, and the Asia Pacific. Founded in 1947, the company was formerly known as Phonak Holding AG before officially changing its name to Sonova Holding AG in August 2007.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
| Fund | Ticker | Position# | Weight |
|---|---|---|---|
| iShares SMIM ETF (CH) | CSSMIM.SW | 8 | 4.65% |
| iShares STOXX Europe Mid 200 UCITS ETF (DE) | EXSD.DE | 10 | 0.80% |
| First Trust International Developed Capital Strength ETF | FICS | 3 | 2.54% |
| Harbor ETF Trust - Harbor Osmosis International Resource Efficient ETF | EFFI | 8 | 3.34% |
Funds with Sonova Holding among their ten largest holdings, largest fund first.
Based on consensus from external analysts. Not Kvantra's opinion.
Headquartered in Stäfa, Switzerland, Sonova Holding AG is a leading provider of innovative hearing care solutions for both adults and children. The company's operations are divided into two primary segments: Hearing Instruments and Cochlear Implants. Sonova's extensive offerings include advanced wireless communication devices, rechargeable hearing aids, wireless headsets, speech-enhanced hearables, premium audiophile headphones, microphones, and wireless transmission systems, alongside comprehensive audiological care services. Its renowned hearing aid brands comprise Phonak, Unitron, and Hansaton, while Advanced Bionics is its flagship for cochlear implants. For consumer audio, Sonova offers products under the Sennheiser brand. The company delivers its audiological care through a vast network of around 3,600 clinics and stores operating under various regional names such as AudioNova, Audium, and Boots Hearingcare, among others. Additionally, its products are distributed via independent partners. Sonova boasts a significant international presence, serving markets across the United States, Europe, the Middle East, Africa, and the Asia Pacific. Founded in 1947, the company was formerly known as Phonak Holding AG before officially changing its name to Sonova Holding AG in August 2007.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free